HRTS vs. CNCR ETF Comparison

Comparison of Tema Cardiovascular and Metabolic ETF (HRTS) to Loncar Cancer Immunotherapy ETF (CNCR)
HRTS

Tema Cardiovascular and Metabolic ETF

HRTS Description

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$30.77

Average Daily Volume

14,144

Number of Holdings *

36

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.22

Average Daily Volume

3,744

Number of Holdings *

67

* may have additional holdings in another (foreign) market
Performance
Period HRTS CNCR
30 Days -9.25% -13.14%
60 Days -11.27% -15.74%
90 Days -12.29% -11.75%
12 Months 15.50% 25.96%
1 Overlapping Holdings
Symbol Grade Weight in HRTS Weight in CNCR Overlap
REGN F 2.37% 1.0% 1.0%
HRTS Overweight 35 Positions Relative to CNCR
Symbol Grade Weight
LLY F 6.44%
VRTX D 5.64%
AMGN F 5.11%
ALNY D 4.95%
CRNX C 4.0%
BBIO F 3.69%
CYTK F 3.47%
BSX A 2.99%
ASND F 2.88%
MDT D 2.79%
MIRM B 2.6%
DXCM C 2.57%
MREO F 2.49%
IONS F 2.42%
MASI B 2.39%
KROS D 2.1%
EW C 1.91%
MLYS F 1.89%
PODD C 1.88%
RCKT F 1.8%
ARWR D 1.76%
RARE F 1.71%
NTLA F 1.66%
MDGL B 1.46%
WST C 1.43%
AKRO B 1.28%
NVS F 1.26%
VKTX F 1.14%
NARI C 0.97%
EWTX C 0.96%
SLN F 0.91%
TERN F 0.7%
VERV F 0.64%
TNYA D 0.43%
RANI F 0.31%
HRTS Underweight 66 Positions Relative to CNCR
Symbol Grade Weight
GLUE C -2.03%
EXEL B -1.9%
RVMD C -1.84%
ACLX C -1.73%
BMY B -1.72%
ELVN D -1.68%
XNCR B -1.66%
MRSN D -1.62%
BPMC B -1.58%
KPTI D -1.57%
REPL D -1.56%
GNLX F -1.56%
MGNX F -1.55%
HCM D -1.54%
SWTX C -1.47%
CRBU D -1.47%
JANX C -1.46%
ERAS C -1.46%
DAWN D -1.44%
IMCR D -1.42%
RXRX F -1.39%
SDGR C -1.39%
ARVN F -1.39%
AURA C -1.38%
LYEL F -1.35%
SNDX F -1.34%
MRUS F -1.33%
KYMR D -1.32%
RPTX F -1.32%
GERN D -1.31%
IOVA F -1.3%
RCUS F -1.29%
NRIX C -1.29%
FHTX C -1.26%
NUVB C -1.26%
BNTX C -1.25%
ZNTL F -1.25%
MRK D -1.24%
BCYC F -1.24%
YMAB F -1.24%
BMEA F -1.22%
PGEN F -1.2%
CGEM F -1.2%
ALLO F -1.18%
NUVL C -1.18%
VOR D -1.17%
GMAB F -1.17%
TYRA F -1.16%
KURA F -1.16%
ACRV F -1.15%
AUTL F -1.13%
STRO F -1.12%
LEGN D -1.1%
IDYA F -1.07%
TSVT F -1.06%
ITOS F -0.98%
IPHA D -0.98%
SMMT D -0.97%
ACET F -0.97%
IMRX F -0.95%
IMTX F -0.93%
RLAY F -0.91%
IGMS F -0.88%
RAPT F -0.88%
FATE F -0.87%
PRLD F -0.55%
Compare ETFs